Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate

Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate

During the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 conference, Drs. Laura Coates and Atul Deodhar debated whether axial psoriatic arthritis (axPsA) is the same as ankylosing spondylitis (AS) with psoriasis. Dr. Coates argued that AS represents a spectrum...

Descripció completa

Dades bibliogràfiques
Autors principals:	Coates, LC, Deodhar, A
Format:	Journal article
Idioma:	English
Publicat:	Journal of Rheumatology Publishing 2023

Ítems similars

Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry
per: Alba Erra, et al.
Publicat: (2022-11-01)

Persistence of secukinumab in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis
per: Elena Conesa-Nicolás, et al.
Publicat: (2021-01-01)

Modern imaging techniques in the diagnosis of axial spondylitis: similarities and differences between axial psoriatic arthritis and ankylosing spondylitis
per: A. V. Sukhinina, et al.
Publicat: (2024-02-01)

Secukinumab for ankylosing spondylitis and psoriatic arthritis
per: Lubrano E, et al.
Publicat: (2016-10-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
per: E. E. Gubar, et al.
Publicat: (2023-08-01)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
per: Coates, L, et al.
Publicat: (2016)

Specific features of axial spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, in persons of different genders
per: A. P. Rebrov, et al.
Publicat: (2015-03-01)

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis
per: Andrea Rubbert-Roth, et al.
Publicat: (2023-11-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
per: M. Rossini, et al.
Publicat: (2015-03-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
per: T. V. Dubinina, et al.
Publicat: (2023-02-01)

Identification of psoriatic arthritis in patients with psoriasis
per: Coates, LC, et al.
Publicat: (2023)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
per: Vivekanantham, A, et al.
Publicat: (2024)

The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study
per: Chia-Jung Tsai, et al.
Publicat: (2023-09-01)

The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis
per: Ahmet Karataş, et al.
Publicat: (2020-10-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
per: Viola Sacchi, et al.
Publicat: (2010-06-01)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
per: Ashley Elliott, et al.
Publicat: (2019-06-01)

How should we define disease and outcomes in axial psoriatic arthritis?
per: Coates, LC
Publicat: (2021)

Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis
per: Bolge SC, et al.
Publicat: (2017-03-01)

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
per: Iain B McInnes, et al.
Publicat: (2020-02-01)

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data
per: Lars Erik Kristensen, et al.
Publicat: (2024-05-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
per: M. Elaine Husni, et al.
Publicat: (2022-03-01)

Ankylosing spondylitis-axial spondyloarthritis
per: Aanand Narayan Malaviya
Publicat: (2017-01-01)

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
per: A. Deodhar, et al.
Publicat: (2019-05-01)

Axial spondyloarthritis and psoriatic arthritis: mostly overlapping or substantially different diseases?
per: Braun, J, et al.
Publicat: (2023)

Methotrexate in psoriasis and psoriatic arthritis
per: Coates, L, et al.
Publicat: (2020)

Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
per: Colombo GL, et al.
Publicat: (2018-08-01)

Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
per: Alexis Ogdie, et al.
Publicat: (2024-09-01)

Short-term Efficacy and Safety of Secukinumab in Pakistani Patients with Ankylosing Spondylitis and Psoriatic Arthritis
per: Sumera Ghani, et al.
Publicat: (2023-06-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
per: Nikolay N. Murashkin, et al.
Publicat: (2020-12-01)

MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis
per: Peter Nash, et al.
Publicat: (2023-10-01)

Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
per: Gia Deyab, et al.
Publicat: (2017-01-01)

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis
per: Peter Nash, et al.
Publicat: (2023-02-01)

Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset
per: Sarah B. Lieber, et al.
Publicat: (2022-04-01)

Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study
per: Joachim Sieper, et al.
Publicat: (2019-06-01)

Impact of biological and non-biological treatment on hematological indices in patients with ankylosing spondylitis and psoriatic arthritis
per: Fatma Mohammed Aboud, et al.
Publicat: (2023-03-01)

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials
per: Gerd R. Burmester, et al.
Publicat: (2024-04-01)

Vagal Nerve Stimulation-Modulation of the Anti-Inflammatory Response and Clinical Outcome in Psoriatic Arthritis or Ankylosing Spondylitis
per: C. Brock, et al.
Publicat: (2021-01-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
per: Krzysztof Bonek, et al.
Publicat: (2022-04-01)

Complications of primary total hip arthroplasty among patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and primary osteoarthritis
per: Qiang Lian, et al.
Publicat: (2022-10-01)

Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
per: Ehab F. Girbash, et al.
Publicat: (2023-01-01)